Work

Serum Neurofilament Light (sNfL) Levels in Patients with Relapsing-remitting Multiple Sclerosis (RRMS) Switching from Natalizumab Every-4-week (Q4W) Dosing to Extended Interval Dosing (EID) (2013)

Year: 2020

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.94.15_supplement.2013

Authors: John Foley, Kuangan Xiong, Tammy Hoyt, Carol Singh, Evan Riddle, Carl de Moor, Nolan Campbell, Tatiana Plavina

Institutions: Rocky Mountain Multiple Sclerosis Clinic, Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3018899791

FWCI: 0.329

Cites:

Cited by: 2

Related to: 10